• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Synageva BioPharma Corp

+ Add to Watchlist

GEVA:US

64.8000 USD 0.2300 0.36%

As of 20:10:00 ET on 09/19/2014.

Company Profile for Synageva BioPharma Corp (GEVA)

Synageva BioPharma Corp. is a clinical stage biopharmaceutical company. The Company is focused on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and unmet medical need.

Contact Information

Synageva BioPharma Corp

128 Spring Street
Suite 520
Lexington, MA 02421
United States
Phone: 1-781-357-9900
Fax: 1-781-357-9901

Key Executives for Synageva BioPharma Corp (GEVA)

Sanj K PatelPresident/CEO/SecretaryCarsten BoessSenior VP/CFO
Glen WilliamsSenior VP:Global Technical OpsMarc E GoldbergSenior VP:Product Dev

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil